With FDA Nod in Lung Cancer, Dizal Now Aims to Best a J&J Drug and Succeed Where Takeda Fell Short
One of the more competitive targets in lung cancer is a certain mutation that has eluded many available targeted therapies. ...
One of the more competitive targets in lung cancer is a certain mutation that has eluded many available targeted therapies. ...
Regeneron Pharmaceuticals is expanding its cancer drug lineup with FDA approval of a bispecific antibody it developed for multiple myeloma, ...
Health Secretary Robert F. Kennedy Jr. is facing renewed scrutiny after declaring the public should "stop trusting experts" while unveiling ...
In a setback to Johnson & Johnson, a federal judge ruled that a U.S. government agency did not violate the ...
A Nektar Therapeutics drug has met the skin clearance goals of a closely watched mid-stage clinical trial in atopic dermatitis. ...
CHICAGO — Late-stage results of Novo Nordisk’s obesity candidate CagriSema suggest the drug is comparable to Eli Lilly’s Zepbound on ...
CHICAGO — Novo Nordisk’s next-generation obesity injection targeting the amylin hormone showed substantial weight loss in an early study, but ...
A Merck drug developed to prevent disease from respiratory syncytial virus (RSV) in infants has won FDA approval, introducing competition ...
Yearly change (95% CI) on the HDDMS, cUHDRS, and cUHDRS components by CAG category. Credit: Brain (2025). DOI: 10.1093/brain/awaf127 A ...
by David J. Neal Credit: Unsplash/CC0 Public Domain Three lots of a drug designed to treat various urinary tract infections ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.